Avenue Therapeutics ATXI
OTC ATXI
$0.40 -0.03 (-6.98%)
At close: Oct 20, 2026 · 4:00 PM EDT

Avenue Therapeutics (ATXI) Asset Utilization Ratio (2025 - 2026)

Updated

Avenue Therapeutics' Asset Utilization Ratio was 0.63 in Q2 2026, up 74.5% from 0.36 a year earlier.

Analysis

Avenue Therapeutics (ATXI) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

For FY2025, Asset Utilization Ratio at Avenue Therapeutics came in at 0.50.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 0.62
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 0.50
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 0.47
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 0.52
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 0.46
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 0.51
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 0.40
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 0.58
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 0.31
10 Avenue Therapeutics 1.32 Mn -9.61 Mn - 0.63
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.63
Dec 31, 2025 0.42
Sep 30, 2025 0.36
Jun 30, 2025 0.36
API Access

Avenue Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ATXI&period=max&api_key=YOUR_API_KEY